304 related articles for article (PubMed ID: 16324959)
1. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients.
Pilsczek FH; Rifkin WD; Walerstein S
Heart Lung; 2005; 34(6):402-5. PubMed ID: 16324959
[TBL] [Abstract][Full Text] [Related]
2. [Monitoring of coagulation status in the physician's laboratory].
Marbet GA
Ther Umsch; 1995 May; 52(5):343-9. PubMed ID: 7770821
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis.
Shorr AF; Jackson WL; Weiss BM; Moores LK
Blood Coagul Fibrinolysis; 2007 Jun; 18(4):309-16. PubMed ID: 17473570
[TBL] [Abstract][Full Text] [Related]
4. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
Toulon P; Ajzenberg N; Smahi M; Guillin MC
Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
[TBL] [Abstract][Full Text] [Related]
5. The precision of duplicate prothrombin time and partial thromboplastin time assays in neonates.
DePalma L; Rush RA; Luban NL
Arch Pathol Lab Med; 1992 Jun; 116(6):657-9. PubMed ID: 1616427
[TBL] [Abstract][Full Text] [Related]
6. Effect of drawing a discard tube on PT and APTT results in healthy adults.
Bamberg R; Cottle JN; Williams JC
Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
[TBL] [Abstract][Full Text] [Related]
7. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
Jonsson M; Hillarp A; Svensson P
Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
[TBL] [Abstract][Full Text] [Related]
8. [Utility of measuring prothrombin and activated partial thromboplastin times in a community hospital].
Las Heras G; Bosch A; Martín E; Rovira M
Sangre (Barc); 1994 Jun; 39(3):177-81. PubMed ID: 7940046
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prothrombin time and partial thromboplastin time.
Lahoti C; Rangwala AF
N J Med; 1992 May; 89(5):375-8. PubMed ID: 1635675
[TBL] [Abstract][Full Text] [Related]
10. Are coagulation studies necessary before percutaneous nephrostomy?
Martin JH; Rosser CJ; Linebach RF; McCullough DL; Assimos DG
Tech Urol; 2000 Sep; 6(3):205-7. PubMed ID: 10963488
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.
Ellis RF; Stephens MA; Sharp GB
Am J Hosp Pharm; 1992 Feb; 49(2):387-94. PubMed ID: 1554003
[TBL] [Abstract][Full Text] [Related]
12. Utility of routine coagulation studies in emergency department patients with suspected acute coronary syndromes.
Schwartz D
Isr Med Assoc J; 2005 Aug; 7(8):502-6. PubMed ID: 16106775
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
14. Reducing the use of coagulation test panels.
Amukele TK; Baird GS; Chandler WL
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):688-95. PubMed ID: 21934488
[TBL] [Abstract][Full Text] [Related]
15. [Is the activated partial thromboplastin time suitable for monitoring of thrombosis therapy with high-dose standard heparin?].
Hürzeler C; von Felten A
Schweiz Med Wochenschr; 1994 Apr; 124(17):712-9. PubMed ID: 8202668
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
Hull RD
Thromb Haemost; 2008 Mar; 99(3):502-10. PubMed ID: 18327398
[TBL] [Abstract][Full Text] [Related]
17. Are baseline prothrombin time/partial thromboplastin time values necessary before instituting anticoagulation?
McKinley L; Wrenn K
Ann Emerg Med; 1993 Apr; 22(4):697-702. PubMed ID: 8457098
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the new antithrombotic drugs.
Walenga JM; Hoppensteadt DA
Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
[TBL] [Abstract][Full Text] [Related]
19. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
20. Problems of anticoagulation with warfarin in hyperthyroidism.
Kellett HA; Sawers JS; Boulton FE; Cholerton S; Park BK; Toft AD
Q J Med; 1986 Jan; 58(225):43-51. PubMed ID: 3704105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
